Long-term outcomes after surgical resection for gastric cancer liver metastasis: An analysis of 64 macroscopically complete resections

Langenbeck's Archives of Surgery

Volumn 397, Issue 6, 2012, Pages 951-957

  Takemura, Nobuyuki ^a   Saiura, Akio ^a   Koga, Rintaro ^a   Arita, Junichi ^a   Yoshioka, Ryuji ^a   Ono, Yoshihiro ^a   Hiki, Naoki ^a   Sano, Takeshi ^a   Yamamoto, Junji ^b   Kokudo, Norihiro ^c   Yamaguchi, Toshiharu ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Gastric cancer liver metastasis (GLM); Liver resection; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROSA; STOMACH CANCER; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84865136371     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-012-0959-z     Document Type: Article

References (44)

1. H Imamura Y Seyama N Kokudo T Aoki K Sano M Minagawa Y Sugawara M Makuuchi 2004 Single and multiple resections of multiple hepatic metastases of colorectal origin Surgery 135 5 508 517 10.1016/j.surg.2003.10.009 15118588 10.1016/j.surg.2003.10.009 (Pubitemid 38586525)
2. A Jemal T Murray E Ward A Samuels RC Tiwari A Ghafoor EJ Feuer MJ Thun 2005 Cancer statistics, 2005 CA Cancer J Clin 55 1 10 30 15661684 10.3322/canjclin.55.1.10 (Pubitemid 40310185)
3. HO Douglass Jr SA Hundahl JS Macdonald VP Khatri 2007 Gastric cancer: D2 dissection or low Maruyama Index-based surgery-a debate Surg Oncol Clin N Am 16 1 133 155 10.1016/j.soc.2006.10.005 17336241 10.1016/j.soc.2006.10.005 (Pubitemid 46343645)
4. S Koga H Kawaguchi H Kishimoto K Tanaka Y Miyano O Kimura R Takeda H Nishidoi 1980 Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasis Am J Surg 140 (3 356 359 6158880 10.1016/0002-9610(80)90167-1 1:STN:280:DyaL3M%2Fjslahtw%3D%3D (Pubitemid 10059599)
5. K Okuyama K Isono IK Juan S Onoda T Ochiai Y Yamamoto Y Koide H Satoh 1985 Evaluation of treatment for gastric cancer with liver metastasis Cancer 55 10 2498 2505 3986746 10.1002/1097-0142(19850515)55:10<2498::AID- CNCR2820551032>3.0.CO;2-S 1:STN:280:DyaL2M7ns1Ggsg%3D%3D (Pubitemid 15115205)
6. Y Sakamoto S Ohyama J Yamamoto K Yamada M Seki K Ohta N Kokudo T Yamaguchi T Muto M Makuuchi 2003 Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients Surgery 133 5 507 511 10.1067/msy.2003.147 12773978 10.1067/msy.2003.147 (Pubitemid 36638222)
7. N Boku S Yamamoto H Fukuda K Shirao T Doi A Sawaki W Koizumi H Saito K Yamaguchi H Takiuchi J Nasu A Ohtsu 2009 Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study Lancet Oncol 10 11 1063 1069 10.1016/S1470-2045(09)70259-1 19818685 10.1016/S1470-2045(09)70259-1 1:CAS:528:DC%2BD1MXhtlGit7bI
8. AI Sarela S Yelluri 2007 Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary? Arch Surg 142 2 143 149 10.1001/archsurg.142.2.143 17309965 10.1001/archsurg.142.2.143 discussion 149 (Pubitemid 46294133)
9. YJ Bang E Van Cutsem A Feyereislova HC Chung L Shen A Sawaki F Lordick A Ohtsu Y Omuro T Satoh G Aprile E Kulikov J Hill M Lehle J Ruschoff YK Kang 2010 Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 9742 687 697 10.1016/S0140-6736(10)61121-X 20728210 10.1016/S0140-6736(10)61121- X 1:CAS:528:DC%2BC3cXhtVymt7zO
10. D Cunningham AF Okines S Ashley 2010 Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 362 9 858 859 10.1056/NEJMc0911925 20200397 10.1056/NEJMc0911925 1:CAS:528:DC%2BC3cXivVOhsLg%3D
11. W Koizumi H Narahara T Hara A Takagane T Akiya M Takagi K Miyashita T Nishizaki O Kobayashi W Takiyama Y Toh T Nagaie S Takagi Y Yamamura K Yanaoka H Orita M Takeuchi 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 3 215 221 10.1016/S1470-2045(08)70035-4 18282805 10.1016/S1470-2045(08) 70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D
12. G Folprecht T Gruenberger WO Bechstein HR Raab F Lordick JT Hartmann H Lang A Frilling J Stoehlmacher J Weitz R Konopke C Stroszczynski T Liersch D Ockert T Herrmann E Goekkurt F Parisi CH Kohne 2010 Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 1 38 47 10.1016/S1470-2045(09)70330-4 19942479 10.1016/S1470-2045(09)70330-4 1:CAS:528:DC%2BC3cXjslKrsA%3D%3D
13. JR Hecht E Mitchell T Chidiac C Scroggin C Hagenstad D Spigel J Marshall A Cohn D McCollum P Stella R Deeter S Shahin RG Amado 2009 A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer J Clin Oncol 27 5 672 680 10.1200/JCO.2008.19.8135 19114685 10.1200/JCO.2008.19.8135 1:CAS:528:DC%2BD1MXjsVCjs74%3D
14. LB Saltz S Clarke E Diaz-Rubio W Scheithauer A Figer R Wong S Koski M Lichinitser TS Yang F Rivera F Couture F Sirzen J Cassidy 2008 Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study J Clin Oncol 26 12 2013 2019 10.1200/JCO.2007.14.9930 18421054 10.1200/JCO.2007.14.9930 1:CAS:528:DC%2BD1cXlvFaqs7g%3D
15. N Kokudo K Tada M Seki H Ohta K Azekura M Ueno T Matsubara T Takahashi T Nakajima T Muto 2001 Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma Am J Surg 181 2 153 159 11425058 10.1016/S0002-9610(00)00560-2 1:STN:280:DC%2BD3MzmtlGgsA%3D%3D (Pubitemid 32406310)
16. MA Choti JV Sitzmann MF Tiburi W Sumetchotimetha R Rangsin RD Schulick KD Lillemoe CJ Yeo JL Cameron 2002 Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 6 759 766 12035031 10.1097/00000658-200206000-00002 (Pubitemid 34547293)
17. TM Pawlik CR Scoggins D Zorzi EK Abdalla A Andres C Eng SA Curley EM Loyer A Muratore G Mentha L Capussotti JN Vauthey 2005 Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases Ann Surg 241 5 715 722 15849507 10.1097/01.sla.0000160703. 75808.7d discussion 722-714 (Pubitemid 40604917)
18. M Rees PP Tekkis FK Welsh T O'Rourke TG John 2008 Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 1 125 135 10.1097/SLA. 0b013e31815aa2c2 18156932 10.1097/SLA.0b013e31815aa2c2
19. MC de Jong C Pulitano D Ribero J Strub G Mentha RD Schulick MA Choti L Aldrighetti L Capussotti TM Pawlik 2009 Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients Ann Surg 250 3 440 448 10.1097/SLA.0b013e3181b4539b 19730175
20. Kanda T, Yajima K, Kosugi SI, Ishikawa T, Ajioka Y, Hatakeyama K (2011) Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study. Gastric Cancer. doi: 10.1007/s10120-011-0100-y
21. Lordick F (2012) To resect or not resect in metastatic gastric cancer: that is the question! Gastric Cancer. doi: 10.1007/s10120-011-0136-z
22. T Ochiai M Sasako S Mizuno T Kinoshita T Takayama T Kosuge S Yamazaki K Maruyama 1994 Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors Br J Surg 81 8 1175 1178 7953354 10.1002/bjs.1800810832 1:STN:280:DyaK2M%2FktFWntQ%3D%3D (Pubitemid 24262949)
23. M Miyazaki H Itoh K Nakagawa S Ambiru H Shimizu A Togawa M Shiobara M Ohtsuka K Sasada Y Shimizu S Yoshioka N Nakajima T Suwa F Kimura 1997 Hepatic resection of liver metastases from gastric carcinoma Am J Gastroenterol 92 3 490 493 9068476 1:STN:280:DyaK2s3itFCgsg%3D%3D (Pubitemid 27108188)
24. S Ambiru M Miyazaki H Ito K Nakagawa H Shimizu H Yoshidome Y Shimizu N Nakajima 2001 Benefits and limits of hepatic resection for gastric metastases Am J Surg 181 3 279 283 11376587 10.1016/S0002-9610(01)00567-0 1:STN:280:DC%2BD3M3ps1ertw%3D%3D (Pubitemid 32480231)
25. K Okano T Maeba K Ishimura Y Karasawa F Goda H Wakabayashi H Usuki H Maeta 2002 Hepatic resection for metastatic tumors from gastric cancer Ann Surg 235 1 86 91 11753046 10.1097/00000658-200201000-00011 (Pubitemid 34062403)
26. A Saiura N Umekita S Inoue T Maeshiro S Miyamoto Y Matsui M Asakage M Kitamura 2002 Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer Hepato-Gastroenterology 49 46 1062 1065 12143202 (Pubitemid 34809787)
27. K Shirabe M Shimada T Matsumata H Higashi Y Yakeishi S Wakiyama Y Ikeda T Ezaki S Fukuzawa K Takenaka K Kishikawa T Ikeda K Taguchi Y Maehara K Sugimachi 2003 Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection Hepato-Gastroenterology 50 53 1560 1563 14571786 (Pubitemid 37186532)
28. R Adam L Chiche T Aloia D Elias R Salmon M Rivoire D Jaeck J Saric YP Le Treut J Belghiti G Mantion G Mentha 2006 Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model Ann Surg 244 4 524 535 10.1097/01.sla.0000239036.46827.5f 16998361
29. R Koga J Yamamoto S Ohyama A Saiura M Seki Y Seto T Yamaguchi 2007 Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors Jpn J Clin Oncol 37 11 836 842 10.1093/jjco/hym113 17928333 10.1093/jjco/hym113 (Pubitemid 350259002)
30. Y Sakamoto T Sano K Shimada M Esaki M Saka T Fukagawa H Katai T Kosuge M Sasako 2007 Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer J Surg Oncol 95 7 534 539 10.1002/jso.20739 17219383 10.1002/jso.20739 (Pubitemid 47177216)
31. SH Cheon SY Rha HC Jeung CK Im SH Kim HR Kim JB Ahn JK Roh SH Noh HC Chung 2008 Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases Ann Oncol 19 6 1146 1153 10.1093/annonc/mdn026 18304963 10.1093/annonc/mdn026 1:STN:280:DC%2BD1czktlSrtg%3D%3D (Pubitemid 351796341)
32. T Hirasawa S Asahara S Fujisaki K Kuraoka K Takano A Kamei T Ikari 2008 Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) for metastatic liver tumors in patients with gastric cancer Nihon Shokakibyo Gakkai Zasshi 105 3 367 372 JST.JSTAGE/nisshoshi/105.367 18332601
33. T Kinoshita A Nashimoto Y Yamamura T Okamura M Sasako J Sakamoto H Kojima M Hiratsuka K Arai M Sairenji N Fukushima H Kimura T Nakajima 2004 Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer Gastric Cancer 7 2 104 109 10.1007/s10120-004- 0278-3 15224197 10.1007/s10120-004-0278-3 1:CAS:528:DC%2BD2cXlt1Gluro%3D (Pubitemid 38899661)
34. S Sakuramoto M Sasako T Yamaguchi T Kinoshita M Fujii A Nashimoto H Furukawa T Nakajima Y Ohashi H Imamura M Higashino Y Yamamura A Kurita K Arai 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 18 1810 1820 10.1056/NEJMoa072252 17978289 10.1056/NEJMoa072252 1:CAS:528:DC%2BD2sXht1Kit7bI (Pubitemid 350044801)
35. SM Strasberg 2005 Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system J Hepatobiliary Pancreat Surg 12 5 351 355 10.1007/s00534-005-0999-7 16258801 10.1007/s00534-005-0999-7 (Pubitemid 41662443)
36. J Leporrier J Maurel L Chiche S Bara P Segol G Launoy 2006 A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer Br J Surg 93 4 465 474 10.1002/bjs.5278 16523446 10.1002/bjs.5278 1:STN:280:DC%2BD287nsFGjsg%3D%3D
37. H Kobayashi H Mochizuki K Sugihara T Morita K Kotake T Teramoto S Kameoka Y Saito K Takahashi K Hase M Oya K Maeda T Hirai M Kameyama K Shirouzu T Muto 2007 Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study Surgery 141 1 67 75 10.1016/j.surg.2006.07.020 17188169 10.1016/j.surg.2006.07.020 (Pubitemid 44918081)
38. K Okuno 2007 Surgical treatment for digestive cancer. Current issues-colon cancer Dig Surg 24 2 108 114 10.1159/000101897 17446704 10.1159/000101897 (Pubitemid 46788276)
39. JT Makela SO Laitinen MI Kairaluoma 1995 Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial Arch Surg 130 10 1062 1067 7575117 10.1001/archsurg.1995.01430100040009 1:STN:280:DyaK28%2FksFGmuw%3D%3D
40. D Schoemaker R Black L Giles J Toouli 1998 Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients Gastroenterology 114 1 7 14 9428212 10.1016/S0016-5085(98)70626-2 1:STN:280:DyaK1c%2FovFyisQ%3D%3D (Pubitemid 28020948)
41. R Adam V Delvart G Pascal A Valeanu D Castaing D Azoulay S Giacchetti B Paule F Kunstlinger O Ghemard F Levi H Bismuth 2004 Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 4 644 657 15383792 discussion 657-648
42. SE Hwang DH Yang CY Kim 2009 Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer World J Surg 33 7 1468 1472 10.1007/s00268-009-0034-2 19381718 10.1007/s00268-009-0034-2
43. GA Tiberio A Coniglio A Marchet D Marrelli S Giacopuzzi L Baiocchi F Roviello G de Manzoni D Nitti SM Giulini 2009 Metachronous hepatic metastases from gastric carcinoma: a multicentric survey Eur J Surg Oncol 35 5 486 491 10.1016/j.ejso.2008.12.017 19171450 10.1016/j.ejso.2008.12.017 1:STN:280:DC%2BD1M3ltlOkuw%3D%3D
44. H Tsujimoto T Ichikura S Ono H Sugasawa S Hiraki N Sakamoto Y Yaguchi K Hatsuse J Yamamoto K Hase 2010 Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer Hepatol Int 4 1 406 413 10.1007/s12072-009-9161-y 20305759 10.1007/s12072-009-9161-y